Analytical accuracy · Concordance · Platform validation

Orthogonal Validation

Studies that compare your assay with an independently validated method, designed and executed to meet analytical validation requirements for regulatory filings.

Independent comparator methods

Prove accuracy against an independent method

As a diagnostic-focused CRO, our team designs and executes studies that compare an assay with an independently validated orthogonal method, for analytical accuracy, concordance, and platform validation.

We offer externally validated solutions across technology types, and our clients include many of the biggest names in diagnostics.

What we deliver

From study design to a submission-ready report

1

Study design

Select the comparator, sample size, and acceptance criteria to fit your regulatory requirements.

2

Sample selection

Source representative samples across the variants, levels, and specimen types you claim.

3

Study execution

Run the comparator method in our CLIA-certified, CAP-accredited laboratory, under protocol.

4

Statistical analysis

Calculate agreement, precision, and confidence intervals, and investigate discordant results.

5

Reporting & gap analysis

Deliver a study report ready for your filing, with a gap analysis against regulatory requirements.

Need a comparator method?

Tell us about your assay and the claims you plan to make. We will recommend a comparator and study design.

Reporting results

Agreement, not sensitivity

When the comparator is not a reference standard, FDA recommends reporting agreement between the two methods rather than sensitivity and specificity, with confidence intervals.

Choosing the comparator and planning how discordant results will be resolved before the study starts keeps the analysis defensible.

Source: FDA, Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests (2007).

Agreement measures

Positive percent agreement (PPA)

Of the samples positive by the comparator, the share also positive by your assay

Negative percent agreement (NPA)

Of the samples negative by the comparator, the share also negative by your assay

Overall percent agreement (OPA)

The share of all samples on which the two methods agree

Product focus: PMA & 510(k)

Studies we perform

We have performed hundreds of studies for our clients, including dozens using orthogonal comparator methods in support of IVD submissions.

Instrument precision & reproducibility

Diagnostic equipment studies with comparison to an orthogonal device.

Assay precision & reproducibility

Diagnostic assay studies with comparison to an orthogonal assay.

Custom orthogonal assays

Custom-developed comparator assays for unique and bespoke applications.

Launch & comparative studies

Product launch validation and comparative studies for marketing claims.

Demonstrate accuracy with confidence.

Tell us about your assay, your comparator options, and your submission timeline.